ClinicalTrials.gov
public full text
Public Domain
HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer
The purpose of this study is to determine the efficacy and safety of Hyperthermic Intravesical Chemotherapy (HIVEC) with Gemcitabine (GEM) after Transurethral Resection of Bladder Tumors (TURBT) in the treatment of medium or high-risk group Non-Muscle-Invasive Bladder Cancer (NMIBC).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC#995419
- A Study of Ta-NPs Plus Radiotherapy for Locally Recurrent Retroperitoneal Sarcoma#858342
- Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors#895477
- Phase II Study of Gemcitabine and TS-1 in Biliary Trat Cancer#1102669
- Study of GemOx and Vandetanib in Advanced Solid Malignancy#1138888
Record · ID 880665
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive